Brown Advisory’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,121
| Closed | -$209K | – | 1131 |
|
|
2021
Q1 | $209K | Sell |
5,121
-519,554
| -99% | -$21.2M | ﹤0.01% | 1019 |
|
|
2020
Q4 | $22.7M | Sell |
524,675
-24,853
| -5% | -$1.08M | 0.04% | 250 |
|
|
2020
Q3 | $30.3M | Buy |
549,528
+7,842
| +1% | +$432K | 0.06% | 194 |
|
|
2020
Q2 | $34.2M | Buy |
541,686
+44,849
| +9% | +$2.83M | 0.08% | 170 |
|
|
2020
Q1 | $25.4M | Buy |
496,837
+6,645
| +1% | +$339K | 0.08% | 180 |
|
|
2019
Q4 | $39M | Buy |
490,192
+34,610
| +8% | +$2.75M | 0.1% | 165 |
|
|
2019
Q3 | $22.1M | Buy |
455,582
+58,953
| +15% | +$2.86M | 0.06% | 232 |
|
|
2019
Q2 | $20.9M | Buy |
396,629
+1,644
| +0.4% | +$86.5K | 0.06% | 236 |
|
|
2019
Q1 | $20.9M | Buy |
394,985
+66,245
| +20% | +$3.51M | 0.06% | 243 |
|
|
2018
Q4 | $13.5M | Buy |
328,740
+141,076
| +75% | +$5.79M | 0.05% | 283 |
|
|
2018
Q3 | $7.13M | Buy |
+187,664
| New | +$7.13M | 0.02% | 387 |
|